Clinical Trials Directory

Trials / Completed

CompletedNCT03522714

Fluid Immersion Simulation (FIS) System Versus Air Fluidized Bed (AFB) System for Pressure Ulcers

A Prospective, Randomized Controlled Trial Evaluating the Effectiveness of the Fluid Immersion Simulation (FIS) System Versus Air Fluidized Bed (AFB) System in the Acute Post-Operative Management of Surgically Closed Pressure Ulcers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Northwestern University · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The primary objective is to compare the efficacy of the FIS on closure rate to the AFB after 2 weeks of operative debridement and closure.

Detailed description

Secondary Objectives: 1. Compare the complication rate in each treatment group during the acute postoperative period (2 weeks). 2. Comparisons of the inflammatory and bacterial microbiomes of pressure ulcers following surgical therapy. 3. Comparisons of baseline patient characteristics and their relationship to both early and late pressure ulcer recurrence, and complication rates. 4. Assessment of outcomes and complications associated with flap technique and surgeon guided descriptions of the operative closure. 5. Compare the absolute costs associated with the FIS System against AFB system. 6. Compare the acceptance of each system by subjects and nursing staff, including the parameter of patient comfort at 7 and 14 days postoperative. 7. Assessing the incidence of complications and additional treatments needed following the two week study period.

Conditions

Interventions

TypeNameDescription
DEVICEFluid Immersion Simulation SystemDolphin Fluid Immersion Simulation® System Mattress will be used
DEVICEAir Fluidized Bed SystemAir Fluidized Bed (Clinitron) will be used.

Timeline

Start date
2015-08-08
Primary completion
2020-12-01
Completion
2020-12-01
First posted
2018-05-11
Last updated
2023-05-03
Results posted
2023-05-03

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03522714. Inclusion in this directory is not an endorsement.